A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS-6615 on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Gilead Sciences, Inc.
Start Date
September 1, 2014
End Date
November 9, 2017
Administered By
Institutes and Centers
Awarded By
Gilead Sciences, Inc.
Start Date
September 1, 2014
End Date
November 9, 2017